These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


269 related items for PubMed ID: 6663754

  • 1. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 8. Preclinical evaluation of the urinary NAG activities and their fluctuations in kidney diseases].
    Ishida M, Fujino N, Maeba T, Sugiyama M, Kanazawa T, Owada S, Inoue T, Ozawa S, Amakawa T.
    Rinsho Byori; 1983 Sep; Spec No 56():132-8. PubMed ID: 6663754
    [No Abstract] [Full Text] [Related]

  • 2. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 6. Preclinical evaluation of the urinary NAG activity and its relation to kidney function tests].
    Sano K, Uno E.
    Rinsho Byori; 1983 Sep; Spec No 56():111-21. PubMed ID: 6663752
    [No Abstract] [Full Text] [Related]

  • 3. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from he kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 5. Preclinical evaluation of the urinary NAG activity and its fluctuations in kidney and liver diseases and diabetes mellitus].
    Kin K, Akiyoshi R, Ohashi M, Nihonyanagi Y.
    Rinsho Byori; 1983 Sep; Spec No 56():102-10. PubMed ID: 6663751
    [No Abstract] [Full Text] [Related]

  • 4. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 4. Preclinical evaluation of the urinary NAG activity and changes in renal diseases].
    Yakata M, Sugita O, Sakai T, Uchiyama K, Wada K.
    Rinsho Byori; 1983 Sep; Spec No 56():90-101. PubMed ID: 6663765
    [No Abstract] [Full Text] [Related]

  • 5. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts].
    Ishida Y, Kawada T, Sugino N.
    Rinsho Byori; 1983 Sep; Spec No 56():160-7. PubMed ID: 6363758
    [No Abstract] [Full Text] [Related]

  • 6. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 2. Preclinical determination of the urinary NAG activities and the test data of patients admitted for multiphasic screening].
    Kiyose H, Tomii M, Shimomura H, Mizuno E, Taguchi I, Inoue Y.
    Rinsho Byori; 1983 Sep; Spec No 56():73-8. PubMed ID: 6663763
    [No Abstract] [Full Text] [Related]

  • 7. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 1. Description of NAG activity determination].
    Noto A, Mori S, Nakamura M, Kitakaze T.
    Rinsho Byori; 1983 Sep; Spec No 56():65-72. PubMed ID: 6663762
    [No Abstract] [Full Text] [Related]

  • 8. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 7. Preclinical evaluation of urinary NAG activity and its fluctuations in primary glomerulonephritis].
    Soejima A, Nagasawa T.
    Rinsho Byori; 1983 Sep; Spec No 56():122-31. PubMed ID: 6663753
    [No Abstract] [Full Text] [Related]

  • 9. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 9. Clinical study of urinary NAG activity in patients with various kidney diseases].
    Suzuki M, Asano Y.
    Rinsho Byori; 1983 Sep; Spec No 56():139-46. PubMed ID: 6663755
    [No Abstract] [Full Text] [Related]

  • 10. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 12. Fluctuations of urinary NAG activities in postcardiotomy renal tubular impairment].
    Nagahama D, Tabata K, Yasuma F.
    Rinsho Byori; 1983 Sep; Spec No 56():168-80. PubMed ID: 6663757
    [No Abstract] [Full Text] [Related]

  • 11. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 3. Preclinical evaluation of the urinary NAG activity and changes in diabetic patients].
    Iimura Y, Shimada I, Ohnuki Y, Kawai T, Sakamoto Y.
    Rinsho Byori; 1983 Sep; Spec No 56():79-89. PubMed ID: 6663764
    [No Abstract] [Full Text] [Related]

  • 12. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment].
    Ishimoto F, Shibazaki T, Murai S, Kodama K, Ohno I, Gomi H.
    Rinsho Byori; 1983 Sep; Spec No 56():147-59. PubMed ID: 6663756
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Early diagnosis of renal ischemia in arterial hypertension by means of urine N-acetyl-beta-D-glucosaminidase (author's transl)].
    García M, Méndez X, Botey A, Pons JM, Revert L.
    Med Clin (Barc); 1981 Sep 25; 77(5):200-4. PubMed ID: 7329141
    [Abstract] [Full Text] [Related]

  • 15. [Study on N-acetyl-beta-glucosaminidase (NAG) activities in the urine. II. The relation between NAG activities and various renal function tests in renal diseases].
    Uno E, Sano K.
    Rinsho Byori; 1984 Apr 25; 32(4):419-24. PubMed ID: 6471495
    [No Abstract] [Full Text] [Related]

  • 16. [Significance of urinary N-acetyl-beta-D-glucosaminidase analysis in clinical tests].
    Sugita O, Yakata M.
    Nihon Rinsho; 1989 Dec 25; 48 Suppl():363-5. PubMed ID: 2621903
    [No Abstract] [Full Text] [Related]

  • 17. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity.
    Price RG.
    Clin Nephrol; 1992 Dec 25; 38 Suppl 1():S14-9. PubMed ID: 1295704
    [Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T, Hirokawa N, Oike S, Maekawa T.
    Res Commun Chem Pathol Pharmacol; 1981 Feb 25; 31(2):313-29. PubMed ID: 7221185
    [Abstract] [Full Text] [Related]

  • 19. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
    Ali-Miraftab H, Bourbouze R, Bondiou MT, Percheron F.
    Pathol Biol (Paris); 1988 Mar 25; 36(3):240-4. PubMed ID: 3283687
    [Abstract] [Full Text] [Related]

  • 20. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)].
    Oudart N, Marcher K, Lacour B, Boulu RG, Guichard C.
    Toxicol Eur Res; 1981 May 25; 3(3):149-51. PubMed ID: 7281165
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.